BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hasseli R, Mueller-Ladner U, Hoyer BF, Krause A, Lorenz HM, Pfeil A, Richter J, Schäfer M, Schmeiser T, Strangfeld A, Schulze-Koops H, Voll RE, Specker C, Regierer AC. Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases. RMD Open 2021;7:e001464. [PMID: 33479021 DOI: 10.1136/rmdopen-2020-001464] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]
Number Citing Articles
1 Gamboa-Cárdenas RV, Barzola-Cerrón S, Toledo-Neira D, Reátegui-Sokolova C, Pimentel-Quiroz V, Zevallos-Miranda F, Alarcón GS, Ugarte-Gil M. Predictors of hospitalization for COVID-19 in patients with autoimmune rheumatic diseases: results from a community cohort follow-up. Clin Rheumatol 2021. [PMID: 34189675 DOI: 10.1007/s10067-021-05833-1] [Reference Citation Analysis]
2 Medeiros-Ribeiro AC, Bonfiglioli KR, Domiciano DS, Shimabuco AY, da Silva HC, Saad CGS, Yuki EFN, Pasoto SG, Araujo CSR, Nakai TL, Silva CA, Pedrosa T, Kupa LVK, Silva MSR, Balbi GGM, Kallas EG, Aikawa NE, Bonfa E. Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis. Ann Rheum Dis 2022:annrheumdis-2021-221735. [PMID: 35135832 DOI: 10.1136/annrheumdis-2021-221735] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Vogel F, Reincke M. Endocrine risk factors for COVID-19: Endogenous and exogenous glucocorticoid excess. Rev Endocr Metab Disord 2021. [PMID: 34241765 DOI: 10.1007/s11154-021-09670-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
4 Ruscitti P, Conforti A, Cipriani P, Giacomelli R, Tasso M, Costa L, Caso F. Pathogenic implications, incidence, and outcomes of COVID-19 in autoimmune inflammatory joint diseases and autoinflammatory disorders. Adv Rheumatol 2021;61:45. [PMID: 34238376 DOI: 10.1186/s42358-021-00204-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Stallmach A, Reuken PA, Grunert P, Teich N. [Inflammatory bowel disease during the COVID-19 pandemic: manifestations and management]. Z Gastroenterol 2022. [PMID: 35148564 DOI: 10.1055/a-1744-6697] [Reference Citation Analysis]
6 Park JK, Lee EB, Shin K, Sung YK, Kim TH, Kwon SR, Lee MS, Hong SJ, Choi BY, Lee SS, Back HJ; Korean College of Rheumatology Task Force for COVID-19 Vaccine Guidance for Patients with Autoimmune Inflammatory Rheumatic Diseases. COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases: Clinical Guidance of the Korean College of Rheumatology. J Korean Med Sci 2021;36:e95. [PMID: 33783147 DOI: 10.3346/jkms.2021.36.e95] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
7 Hasseli R, Pfeil A, Hoyer BF, Lorenz HM, Regierer AC, Richter JG, Schmeiser T, Strangfeld A, Voll RE, Krause A, Schulze-Koops H, Müller-Ladner U, Specker C. [German registry www.Covid19-Rheuma.de : Status report after 1 year of the pandemic]. Z Rheumatol 2021;80:641-6. [PMID: 34196793 DOI: 10.1007/s00393-021-01034-y] [Reference Citation Analysis]
8 Regierer AC, Hasseli R, Schäfer M, Hoyer BF, Krause A, Lorenz HM, Pfeil A, Richter J, Schmeiser T, Schulze-Koops H, Strangfeld A, Voll RE, Specker C, Mueller-Ladner U. TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMD. RMD Open 2021;7:e001896. [PMID: 34670840 DOI: 10.1136/rmdopen-2021-001896] [Reference Citation Analysis]
9 Pinte L, Caraiola S, Balaban DV, Badea C, Mazilu D, Ionescu GD, Iosub MI, Bălan ES, Negoi F, Dumitrescu B, Mateescu B, Ionescu R, Parvu MI, Baicus C. COVID-19 Impact and Vaccination Willingness among Romanian Patients with Autoimmune/Immune-Mediated Diseases. Healthcare (Basel) 2021;9:1707. [PMID: 34946433 DOI: 10.3390/healthcare9121707] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Álvaro Gracia JM, Sanchez-Piedra C, Manero J, Ruiz-Lucea ME, López-Vives L, Bohorquez C, Martinez-Barrio J, Bonilla G, Vela P, García-Villanueva MJ, Navío-Marco MT, Pavía M, Galindo M, Erausquin C, Gonzalez-Gay MA, Rua-Figueroa I, Pego-Reigosa JM, Castrejon I, Sanchez-Costa JT, González-Dávila E, Diaz-Gonzalez F; COVIDSER study group. Role of targeted therapies in rheumatic patients on COVID-19 outcomes: results from the COVIDSER study. RMD Open 2021;7:e001925. [PMID: 34887346 DOI: 10.1136/rmdopen-2021-001925] [Reference Citation Analysis]
11 Moss P, Berenbaum F, Curigliano G, Grupper A, Berg T, Pather S. Benefit–Risk Evaluation of COVID-19 Vaccination in Special Population Groups of Interest. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.05.067] [Reference Citation Analysis]
12 Boekel L, Steenhuis M, Hooijberg F, Besten YR, van Kempen ZLE, Kummer LY, van Dam KPJ, Stalman EW, Vogelzang EH, Cristianawati O, Keijzer S, Vidarsson G, Voskuyl AE, Wieske L, Eftimov F, van Vollenhoven R, Kuijpers TW, van Ham SM, Tas SW, Killestein J, Boers M, Nurmohamed MT, Rispens T, Wolbink G. Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies. Lancet Rheumatol 2021. [PMID: 34396154 DOI: 10.1016/S2665-9913(21)00222-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
13 Picchianti Diamanti A, Rosado MM, Nicastri E, Sesti G, Pioli C, Laganà B. Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Autoimmunity 1 Year Later: The Era of Vaccines. Front Immunol 2021;12:708848. [PMID: 34659200 DOI: 10.3389/fimmu.2021.708848] [Reference Citation Analysis]
14 Jatoi HN, Abbas S, Abbasi MS, Tauni MA, Ghazanfar S, Zafar Malick MD, Umar MF, Tahir MJ, Asghar MS, Ahmed A. BNT162b2 vaccine considerations for immunocompromised individuals: A global perspective. Ann Med Surg (Lond) 2022;78:103796. [PMID: 35603097 DOI: 10.1016/j.amsu.2022.103796] [Reference Citation Analysis]
15 Geisen UM, Berner DK, Tran F, Sümbül M, Vullriede L, Ciripoi M, Reid HM, Schaffarzyk A, Longardt AC, Franzenburg J, Hoff P, Schirmer JH, Zeuner R, Friedrichs A, Steinbach A, Knies C, Markewitz RD, Morrison PJ, Gerdes S, Schreiber S, Hoyer BF. Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort. Ann Rheum Dis 2021;80:1306-11. [PMID: 33762264 DOI: 10.1136/annrheumdis-2021-220272] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 56.0] [Reference Citation Analysis]
16 Abe K, Ishikawa Y, Kita Y, Yajima N, Inoue E, Sada KE, Miyawaki Y, Yoshimi R, Shimojima Y, Ohno S, Kajiyama H, Ichinose K, Sato S, Fujiwara M. Association of low-dose glucocorticoid use and infection occurrence in systemic lupus erythematosus patients: a prospective cohort study. Arthritis Res Ther 2022;24:179. [PMID: 35902976 DOI: 10.1186/s13075-022-02869-9] [Reference Citation Analysis]
17 Nuñez DF, Leon L, Garcia AM, Arce JIC, Mucientes A, Gutierrez-fernandez B, Rodriguez L, Cristóbal IPS, Álvarez P, Prada CM, Abasolo L. Mortality related to COVID-19 in patients with rheumatic and musculoskeletal diseases, first wave of the outbreak: a single-center study. Therapeutic Advances in Musculoskeletal 2022;14:1759720X2210902. [DOI: 10.1177/1759720x221090296] [Reference Citation Analysis]
18 Favalli EG, Maioli G, Biggioggero M, Caporali R. Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemic. Expert Rev Clin Immunol 2021;17:561-71. [PMID: 33787418 DOI: 10.1080/1744666X.2021.1908887] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Louis TJ, Qasem A, Abdelli LS, Naser SA. Extra-Pulmonary Complications in SARS-CoV-2 Infection: A Comprehensive Multi Organ-System Review. Microorganisms 2022;10:153. [PMID: 35056603 DOI: 10.3390/microorganisms10010153] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 Raza HA, Sen P, Bhatti OA, Gupta L. Sex hormones, autoimmunity and gender disparity in COVID-19. Rheumatol Int 2021;41:1375-86. [PMID: 33903964 DOI: 10.1007/s00296-021-04873-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Belleudi V, Rosa AC, Poggi FR, Armuzzi A, Nicastri E, Goletti D, Diamanti AP, Davoli M, Agabiti N, Addis A. Direct and Indirect Impact of COVID-19 for Patients with Immune-Mediated Inflammatory Diseases: A Retrospective Cohort Study. J Clin Med 2021;10:2388. [PMID: 34071452 DOI: 10.3390/jcm10112388] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Pinte L, Caraiola S, Balaban DV, Badea C, Mazilu D, Ionescu GD, Iosub M, Bălan E, Negoi F, Dumitrescu B, Mateescu B, Ionescu R, Parvu MI, Baicus C. COVID-19 Impact and Vaccination Willingness among Romanian Patients with Autoimmune/Immune-Mediated Diseases. Healthcare 2021;9:1707. [DOI: 10.3390/healthcare9121707] [Reference Citation Analysis]
23 Dalili D, Fairhead R, Mermekli A, Papanikitas J, Teh J, Hughes R, Fascia D, McKean D. Impact of the COVID-19 pandemic on corticosteroid injection services: A National Survey of Members of the British Society of Skeletal Radiologists (BSSR). Br J Radiol 2021;94:20210327. [PMID: 34520669 DOI: 10.1259/bjr.20210327] [Reference Citation Analysis]
24 Thiele T, Beider S, Kühl H, Mielke G, Holz A, Hirsch S, Witte T, Hoeper K, Cossmann A, Happle C, Jablonka A, Ernst D. [Care of rheumatology patients during the lockdown in early 2020 : Telemedicine, delegation, patient satisfaction and vaccination behavior]. Z Rheumatol 2021. [PMID: 33974131 DOI: 10.1007/s00393-021-01005-3] [Reference Citation Analysis]
25 Ammitzbøll C, Bartels LE, Bøgh Andersen J, Risbøl Vils S, Elbaek Mistegård C, Dahl Johannsen A, From Hermansen ML, Kragh Thomsen M, Erikstrup C, Hauge EM, Troldborg A. Impaired Antibody Response to the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis. ACR Open Rheumatol 2021. [PMID: 34273260 DOI: 10.1002/acr2.11299] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Teich N, Ludewig C, Schmelz R, Bästlein EC, Geißler S, Nagl S, Walldorf J, Krause T, Maaser C, Mohl W, Wedemeyer HH, Bauer T, Büning C, Grunert P, Hasselblatt P, Hänschen M, Kahl M, Engelke O, Schubert S, Holler B, Streetz K, Arnim UV, Schmidt K, Stallmach A; für die German IBD Study Group., Collaborators:., Jochen Maul, Berlin., Axel Schweitzer, Münster., Wolfgang Breit, Dinkelsbühl., Jan-Hinnerk Hofer, Köln., Marc Eisold, Mössingen., Michael R. Mroß, Berlin., Stefanie Howaldt, Hamburg., Stefanie Strobl, Ingolstadt., Robert Ehehalt, Heidelberg., Klaus Schmidt, Lübeck., Carsten Triller, Heinsberg., Serhat Aymaz, Düren., Thorsten Brechmann, Bochum., Axel Dignaß, Frankfurt., Elisabeth Schnoy, Augsburg., Bernd Swarovsky, Albstadt., Dr. med. Birgit Gerhard, Berlin., Doris Zink, Nürnberg., Ulrich Finger, Berlin., Franz Josef Heil, Andernach., Gerd-Rüdiger Franke, Dinkelsbühl., Günther Böhm, Ludwigshafen., Jens Hunkemöller, Oberberg., Martin Schmidt-Lauber, Oldenburg., Mirko Vonderach, Oldenburg., Olaf Mensler, Oberberg., Rainer Kunz, Fürstenfeldbruck., Richard Kölble, Düsseldorf., Christoph Rother, Sundern., Ulf Klönne, Göttingen., Ulrich Graefe, Berlin., Wolfgang Schwarz, Hamburg., Georg Schmitz, Düren., Hans Vibrans, Chemnitz., Thomas Witthöft, Stade., Tobias Klugmann, Leipzig., Martin Reuther, Lilienthal., Frank Bülow, Kassel., Carsten Ising, Waldbröl., Christoph Balzer, Schwandorf., Julia Morgenstern, Köln., Markus Casper, Saarbrücken., Ron Winograd, Aachen., Tilman Pickartz, Greifswald., Marco Wagner, Wipperfürth., Christoph Schmidt, Bonn., Wolfgang Vogt, Esslingen., Sabine Blau, Frankfurt/Main., Rolf Seipel, Kronach., Gisela Felten, Herne., Philipp A. Reuken, Jena., Jörg Kapp, Uelzen., Maximilian Gemeinhardt, Garmisch-Partenkirchen., Jörg Christian Metzler, Schwäbisch Gmünd., Martin Hoffstadt, Iserlohn., Susanne Wüchner-Hofmann, Darmstadt. [Effects of SARS-CoV-2 Infection on Symptoms and Therapy of Inflammatory Bowel Disease]. Z Gastroenterol 2021;59:1189-96. [PMID: 34748206 DOI: 10.1055/a-1508-6734] [Reference Citation Analysis]
27 Araujo CSR, Medeiros-Ribeiro AC, Saad CGS, Bonfiglioli KR, Domiciano DS, Shimabuco AY, Silva MSR, Yuki EFN, Pasoto SG, Pedrosa T, Kupa LVK, Zou G, Pereira RMR, Silva CA, Aikawa NE, Bonfa E. Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial. Ann Rheum Dis 2022:annrheumdis-2021-221916. [PMID: 35193873 DOI: 10.1136/annrheumdis-2021-221916] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
28 Dalili D, Fritz J, Isaac A. 3D MRI of the Hand and Wrist: Technical Considerations and Clinical Applications. Semin Musculoskelet Radiol 2021;25:501-13. [PMID: 34547815 DOI: 10.1055/s-0041-1731652] [Reference Citation Analysis]
29 Deodhar A, Bhana S, Winthrop K, Gensler LS. COVID-19 Outcomes and Vaccination in Patients with Spondyloarthritis. Rheumatol Ther. [DOI: 10.1007/s40744-022-00462-9] [Reference Citation Analysis]
30 Specker C, Aries P, Braun J, Burmester G, Fischer-Betz R, Hasseli R, Holle J, Hoyer BF, Iking-Konert C, Krause A, Krüger K, Krusche M, Leipe J, Lorenz HM, Moosig F, Schmale-Grede R, Schneider M, Strangfeld A, Voll R, Voormann A, Wagner U, Schulze-Koops H. [Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV‑2/COVID‑19 pandemic, including recommendations for COVID‑19 vaccination]. Z Rheumatol 2021;80:570-87. [PMID: 34309739 DOI: 10.1007/s00393-021-01056-6] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
31 Moreno-Torres V, Mendoza C, Mellor-Pita S, Martínez-Urbistondo M, Durán-Del Campo P, Tutor-Ureta P, Vázquez-Comendador JM, Calderón-Parra J, Múñez-Rubio E, Ramos-Martínez A, Fernández-Cruz A, Castejón R, Vargas-Nuñez JA. Systemic Autoimmune Diseases in Patients Hospitalized with COVID-19 in Spain: A Nation-Wide Registry Study. Viruses 2022;14:1631. [PMID: 35893696 DOI: 10.3390/v14081631] [Reference Citation Analysis]
32 Wang F, Ma Y, Xu S, Liu H, Chen Y, Yang H, Shao M, Xu W, Kong J, Chen L, Xu S, Shuai Z, Pan F. Prevalence and risk of COVID-19 in patients with rheumatic diseases: a systematic review and meta-analysis. Clin Rheumatol 2022. [PMID: 35352217 DOI: 10.1007/s10067-022-06087-1] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Hasseli R, Ladner UM. [COVID-19 and inflammatory rheumatic diseases]. Dtsch Med Wochenschr 2021;146:1564-8. [PMID: 34826845 DOI: 10.1055/a-1616-8742] [Reference Citation Analysis]
34 Ugarte-Gil MF, Alarcón GS, Izadi Z, Duarte-García A, Reátegui-Sokolova C, Clarke AE, Wise L, Pons-Estel GJ, Santos MJ, Bernatsky S, Ribeiro SLE, Al Emadi S, Sparks JA, Hsu TY, Patel NJ, Gilbert EL, Valenzuela-Almada MO, Jönsen A, Landolfi G, Fredi M, Goulenok T, Devaux M, Mariette X, Queyrel V, Romão VC, Sequeira G, Hasseli R, Hoyer B, Voll RE, Specker C, Baez R, Castro-Coello V, Maldonado Ficco H, Reis Neto ET, Ferreira GAA, Monticielo OAA, Sirotich E, Liew J, Hausmann J, Sufka P, Grainger R, Bhana S, Costello W, Wallace ZS, Jacobsohn L, Taylor T, Ja C, Strangfeld A, Mateus EF, Hyrich KL, Carmona L, Lawson-Tovey S, Kearsley-Fleet L, Schäfer M, Machado PM, Robinson PC, Gianfrancesco M, Yazdany J. Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance. Ann Rheum Dis 2022:annrheumdis-2021-221636. [PMID: 35172961 DOI: 10.1136/annrheumdis-2021-221636] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
35 Specker C, Aries P, Braun J, Burmester G, Fischer-Betz R, Hasseli R, Holle J, Hoyer BF, Iking-Konert C, Krause A, Krüger K, Krusche M, Leipe J, Lorenz HM, Moosig F, Schmale-Grede R, Schneider M, Strangfeld A, Voll R, Voormann A, Wagner U, Schulze-Koops H. Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic, including recommendations for COVID-19 vaccination. Z Rheumatol 2021. [PMID: 34491403 DOI: 10.1007/s00393-021-01055-7] [Reference Citation Analysis]
36 Boyarchuk O, Predyk L, Yuryk I. COVID-19 in patients with juvenile idiopathic arthritis: frequency and severity. Reumatologia 2021;59:197-9. [PMID: 34538947 DOI: 10.5114/reum.2021.107590] [Reference Citation Analysis]
37 Ferri C, Ursini F, Gragnani L, Raimondo V, Giuggioli D, Foti R, Caminiti M, Olivo D, Cuomo G, Visentini M, Cacciapaglia F, Pellegrini R, Pigatto E, Urraro T, Naclerio C, Tavoni A, Puccetti L, Varcasia G, Cavazzana I, L'Andolina M, Ruscitti P, Vadacca M, Gigliotti P, La Gualana F, Cozzi F, Spinella A, Visalli E, Dal Bosco Y, Amato G, Masini F, Pagano Mariano G, Brittelli R, Aiello V, Caminiti R, Scorpiniti D, Rechichi G, Ferrari T, Monti M, Elia G, Franceschini F, Meliconi R, Casato M, Iannone F, Giacomelli R, Fallahi P, Santini SA, Zignego AL, Antonelli A. Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups. J Autoimmun 2021;125:102744. [PMID: 34781162 DOI: 10.1016/j.jaut.2021.102744] [Reference Citation Analysis]